blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1420812

EP1420812 - USE OF LEPTIN FOR INFANT WITH LOW BIRTH WEIGHT FOR PREVENTION OF OBESITY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.02.2010
Database last updated on 02.11.2024
Most recent event   Tooltip26.02.2010Application deemed to be withdrawnpublished on 31.03.2010  [2010/13]
Applicant(s)For all designated states
The University of Buckingham
Yeomanry House Buckingham
Buckinghamshire MK18 1EG / GB
[N/P]
Former [2004/22]For all designated states
The University of Buckingham
Yeomanry House
Buckingham, Buckinghamshire MK18 1EG / GB
Inventor(s)01 / CAWTHORNE, Michael Anthony
Clore Lab., University of Buckingham, Hunter Str.
Buckingham, Buckinghamshire MK18 1EG / GB
02 / STOCKER, Claire Joanne
Clore Lab., University of Buckingham, Hunter Str.
Buckingham, Buckinghamshire MK18 1EG / GB
 [2004/22]
Representative(s)Forrest, Graham Robert
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2004/22]Forrest, Graham Robert
Mewburn Ellis, York House, 23 Kingsway
London WC2B 6HP / GB
Application number, filing date02755262.928.08.2002
[2004/22]
WO2002GB03955
Priority number, dateGB2001002088429.08.2001         Original published format: GB 0120884
GB2002001193623.05.2002         Original published format: GB 0211936
[2004/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03020303
Date:13.03.2003
Language:EN
[2003/11]
Type: A1 Application with search report 
No.:EP1420812
Date:26.05.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 13.03.2003 takes the place of the publication of the European patent application.
[2004/22]
Search report(s)International search report - published on:EP13.03.2003
ClassificationIPC:A61K38/22, A23C9/152, A61P3/04
[2009/23]
CPC:
A61K38/2264 (EP,US); A23C9/152 (EP,US); A23L33/18 (EP,US);
A61P3/04 (EP)
Former IPC [2004/22]A61K38/22, A23C9/152
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/22]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:VERWENDUNG VON LEPTIN FÜR KINDER MIT NIEDRIGEM GEBURTSGEWICHT ZUR VORBEUGUNG VON FETTLEIBIGKEIT[2004/22]
English:USE OF LEPTIN FOR INFANT WITH LOW BIRTH WEIGHT FOR PREVENTION OF OBESITY[2004/22]
French:UTILISATION DE LEPTINE CHEZ LES ENFANTS DE FAIBLE POIDS A LA NAISSANCE POUR LA PREVENTION DE L'OBESITE[2004/22]
Entry into regional phase22.03.2004National basic fee paid 
22.03.2004Designation fee(s) paid 
22.03.2004Examination fee paid 
Examination procedure21.03.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.03.2004Examination requested  [2004/22]
07.12.2006Despatch of a communication from the examining division (Time limit: M06)
06.06.2007Reply to a communication from the examining division
28.05.2009Communication of intention to grant the patent
08.10.2009Application deemed to be withdrawn, date of legal effect  [2010/13]
13.11.2009Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2010/13]
Fees paidRenewal fee
24.08.2004Renewal fee patent year 03
23.08.2005Renewal fee patent year 04
22.08.2006Renewal fee patent year 05
22.08.2007Renewal fee patent year 06
21.08.2008Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.08.200908   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9951253  (IMP COLLEGE INNOVATIONS LTD [GB], et al) [X] 16 * page 21, lines 3-15; claims 1,5,6,27 *;
 [X]WO0047741  (AMGEN INC [US]) [X] 25-28 * page 7, lines 3-31 * * page 39, lines 25-29 *;
 [PX]US2002015709  (KIRWIN SUSAN M [US], et al) [PX] 1-6,16-23,25-29 * the whole document *
 [A]  - BRYSON J.M., "The future of leptin and leptin analogues in the treatment of obesity.", DIABETES, OBESITY AND METABOLISM, (2000) 2/2 (83-89)., XP002219935 [A] 1-14,16-30 * the whole document *

DOI:   http://dx.doi.org/10.1046/j.1463-1326.2000.00052.x
 [A]  - PHILLIPS D I W ET AL, "Birth and infant weight and serum leptin concentrations in adult life.", JOURNAL OF ENDOCRINOLOGY, 18th Joint Meeting of the British Endocrine Societies;Bournemouth, England, UK; April 12-15, 1999, (199903), vol. 160, no. SUPPL., ISSN 0022-0795, page P89, XP009000249 [A] 1-14,16-30 * the whole document *
 [AD]  - SECKL JONATHAN R ET AL, "Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming.", KIDNEY INTERNATIONAL, (200004), vol. 57, no. 4, ISSN 0085-2538, pages 1412 - 1417, XP002219936 [AD] 7-14,17,24,30 * the whole document *

DOI:   http://dx.doi.org/10.1046/j.1523-1755.2000.00984.x
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.